Back to Trades
Sell4
Pacira BioSciences, Inc.
PCRX
Total Value
$699.3K
Net $302.6K sold
Sales
$302.6K
3 transactions
Company Information
- Company Name
- Pacira BioSciences, Inc.
- Ticker Symbol
- PCRX
- CIK
- 0001396814
Insider Information
- Name
- Cross Shawn
- Role
- Chief Financial Officer
- Location
- BRISBANE, CA
Officer
Filing Details
- Filing Date
- Apr 22, 2026
- Transaction Date
- Apr 20, 2026
- Accession Number
- 0001628280-26-026669
- Form Type
- 4
- Net Trading Amount
- -$302.6K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | 7,714 | $16.45 | Exercise | $126.9K |
| Apr 20, 2026 | Common Stock | 7,714 | $25.14 | Sale | $193.9K |
| Apr 21, 2026 | Common Stock | 2,845 | $16.45 | Exercise | $46.8K |
| Apr 21, 2026 | Common Stock | 2,845 | $25.01 | Sale | $71.2K |
| Apr 22, 2026 | Common Stock | 1,500 | $16.45 | Exercise | $24.7K |
| Apr 22, 2026 | Common Stock | 1,500 | $25.01 | Sale | $37.5K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Derivative | 7,714 | $16.45 | Exercise | $126.9K |
| Apr 21, 2026 | Derivative | 2,845 | $16.45 | Exercise | $46.8K |
| Apr 22, 2026 | Derivative | 1,500 | $16.45 | Exercise | $24.7K |
Footnotes
- (F1)The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on June 9, 2025.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.31, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2 and 3.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.04, inclusive.
- (F4)The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date.